Topic: Cerebrovascular Diseases

Download All Articles

A special issue of Vessel Plus (Online ISSN:2574-1209).

Deadline for manuscript submissions: 30 Jun 2018

Share This Special Issue

Guest Editor(s)

  • Prof. Aaron S. Dumont, MD
    The Charles B. Wilson Professor and Chair of the Department of Neurosurgery, Director of The Tulane Center for Clinical Neurosciences, Tulane University School of Medicine, USA.

    Website | E-mail

Special Issue Introduction:

Stroke is the fourth leading cause of death and the leading cause of disability in the United States. As both a common and devastating disease process, efforts focused on improving our understanding and treatment of cerebrovascular diseases are urgently needed. We are hereby soliciting manuscripts for this special issue dedicated to basic cerebrovascular biology as well as clinical and translational research focused on the diagnosis and treatment of cerebrovascular diseases including ischemic stroke, hemorrhagic stroke. Articles addressing acute ischemic intervention, stroke rehabilitation, cerebral aneurysms, cerebral vascular malformations, Moyamoya disease and extracranial and intracranial atherosclerotic disease are especially encouraged.

Keywords:

Ischemic stroke, hemorrhagic stroke, acute ischemic intervention, stroke rehabilitation, cerebral aneurysms, cerebral vascular malformations, Moyamoya disease, extracranial and intracranial atherosclerotic disease

Submission Information:

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to http://vpjournal.net/pages/view/author_instructions
For Online Submission, please login at http://vpjournal.net/login
Submission Deadline: 30 Jun 2018
Contacts: Sylvia Wang, Managing Editor, editorialoffice@vpjournal.net

Published Articles Download All Articles
  • Plasmatic biomarkers of inflammation correlate with 18FDG-PET-CT and microembolic signals in patients with carotid stenosis

    Hubertus Mueller , Loraine Fisch , Christophe Bonvin , Karl Lovblad , Osman Ratib , Patrice Lalive , Stephane Pagano , Nicolas Vuilleumier , Jean-Pierre Willi , Roman Sztajzel
    Aim: To determine whether plasmatic biomarkers correlate with 18fluoro-2-deoxy-D-glucose (FDG) positron emission tomography/computed tomography (PET-CT) and presence of microembolic signals (MES) detected by transcranial Doppler in patients with carotid stenosis. Methods: 18FDG-PET-CT and MES detection was performed in consecutive patients with 50% to 99% symptomatic or asymptomatic carotid stenosis. Uptake index was defined by a target to background ratio (TBR) between maximum standardized uptake value of the carotid plaque and the average uptake of the jugular veins. The analysis of... Read more
    This article belongs to the Special Issue Cerebrovascular Diseases
    Vessel Plus 2018;2:13. | doi:10.20517/2574-1209.2018.19
    Published on: 5 Jun 2018  | Viewed:214  | Downloaded:12
    +HTML| PDF
  • Bortezomib-induced posterior reversible encephalopathy syndrome: a case report

    Paolo Candelaresi , Maria Chiara Casorio
    Posterior reversible encephalopathy syndrome (PRES) is an uncommon neurological syndrome due to autoregulation breakthrough with subsequent predominantly vasogenic oedemain associated with several clinical conditions. It is being increasingly reported in antineoplastic-treated patients. Here we report the case of a 72-year-old man who developed PRES during the second cycle of bortezomib treatment for multiple myeloma. Unlike usual PRES cases, only moderate hypertension was present at symptom onset, supporting the hypothesis that alterations of the vascular endothelium and... Read more
    This article belongs to the Special Issue Cerebrovascular Diseases
    Vessel Plus 2018;2:11. | doi:10.20517/2574-1209.2018.09
    Published on: 18 May 2018  | Viewed:208  | Downloaded:19
    +HTML| PDF
  • Adherence to guidelines: primary prevention with aspirin in 1125 medical check-up participants

    Jin Hee Im , Sang Won Han , Seon Yeong Lee , Jong Sam Baik
    Aim: The aim of the present study was to assess the 10-year cardiovascular disease (CVD) risk and to apply the current recommendations on aspirin use for primary prevention in Korean participants undergoing a medical check-up. Methods: Adults aged 50 to 69 years were eligible for the study if they did not have a history of atherosclerotic CVD (ASCVD) or stroke. The 10-year CVD risk was calculated using the ASCVD risk estimator (http://tools.acc.org/ASCVD-Risk-Estimator). Results: A total of 1125 participants were enrolled in this study. The mean age was 57 years, and 32% of the participants... Read more
    This article belongs to the Special Issue Cerebrovascular Diseases
    Vessel Plus 2018;2:5. | doi:10.20517/2574-1209.2018.07
    Published on: 18 Apr 2018  | Viewed:548  | Downloaded:27
    +HTML| PDF
Vessel Plus ISSN 2574-1209 (Online)
Partners
Copyright © 2018 OAE Publishing Inc. All Rights Reserved.